Liahng-Yim Liu

Title: Liahng-Yim Liu: Innovator in Therapeutic Antibodies

Introduction

Liahng-Yim Liu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on creating innovative solutions for cancer treatment and detection.

Latest Patents

Liahng-Yim Liu holds a patent for therapeutic antibodies. The patent discloses humanized antibodies, antigen-binding fragments, and antibody conjugates that specifically bind to biantennary Lewis antigens expressed in various cancers. These antibodies are designed to target antigen-expressing cells, facilitating the treatment and detection of diseases, including different types of cancer. The patent also includes polynucleotides, vectors, and host cells for producing the disclosed antibodies and their fragments. Additionally, it outlines pharmaceutical compositions, methods of treatment and detection, and various uses of the antibodies and compositions.

Career Highlights

Liahng-Yim Liu is associated with Glyconex, Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to the fight against cancer through his patented technologies.

Collaborations

Liahng-Yim Liu collaborates with talented individuals in his field, including Tong-Hsuan Chang and Mei-Chun Yang. Their combined expertise enhances the research and development efforts at Glyconex, Inc., fostering an environment of innovation and discovery.

Conclusion

Liahng-Yim Liu's contributions to therapeutic antibodies represent a significant advancement in cancer treatment and detection. His innovative spirit and collaborative efforts continue to drive progress in biotechnology.